Stock research
GSK — GSK PLC
GSK is reported by 13 tracked managers with $4.0B in visible reported value. This page connects ownership breadth, filing activity, and price context.
Stock research evidence
The latest visible filing snapshot is 2026 Q2. Values come from reported manager holdings; prices and 52-week context come from the latest available market quote.
- Tracked holders
- 13
- Reported value
- $4.0B
- Ownership breadth
- Not available
- Current price
- $50
Top reported managers
These managers have the largest visible reported positions in GSK. Portfolio weight is measured within each manager's latest visible filing.
- Dodge & Cox Funds1.3% of reported portfolio · $2.5B · Reduce · Filed Aug 13, 2026
- Primecap0.8% of reported portfolio · $1.3B · Reduce · Filed Aug 14, 2026
- David Shaw0% of reported portfolio · $53.4M · Buy · Filed Aug 14, 2026
- Ray Dalio0.1% of reported portfolio · $26.4M · Reduce · Filed Aug 14, 2026
- Cliff Asness0% of reported portfolio · $18.1M · Filed Aug 14, 2026
Continue the research
Review the manager roster, compare this company with the most widely held stocks, or browse transparent screens built from the same filing-backed data.